Samsung Biologics' net zooms 134% in Q2
Samsung Biologics’ net profit jumped 133.6 percent in the second quarter to 121.5 billion won ($105.3 million), according to a company regulatory filing on Tuesday. It beat the market consensus of 83.8 billion won compiled by FnGuide.